...
首页> 外文期刊>International journal of molecular medicine >Knockdown of long non-coding RNA metastasis associated lung adenocarcinoma transcript 1 inhibits the proliferation and migration of bladder cancer cells by modulating the microRNA-34a/cyclin D1 axis
【24h】

Knockdown of long non-coding RNA metastasis associated lung adenocarcinoma transcript 1 inhibits the proliferation and migration of bladder cancer cells by modulating the microRNA-34a/cyclin D1 axis

机译:长期非编码RNA转移相关肺腺癌转录物1抑制膀胱癌细胞的增殖和迁移通过调节MicroRNA-34A / Cyclin D1轴来抑制膀胱癌细胞的增殖和迁移

获取原文
获取原文并翻译 | 示例
           

摘要

Long non-coding RNA (lncRNA) metastasis associated lung adenocarcinoma transcript 1 (MALAT1) has been demonstrated to participate in the development and progression of some common cancer types, including bladder cancer (BC). However, the regulatory mechanism of MALAT1 underlying BC growth and metastasis remains to be fully elucidated. The present study revealed that MALAT1 was significantly upregulated in BC tissues and cell lines compared with the adjacent non-tumour tissues and the normal urinary tract epithelial cell line SV-HUC-1, respectively. The expression levels of MALAT1 were higher in stage III-IV BC tissues when compared with that in stage I-II tissues. Furthermore, knockdown of MALAT1 significantly inhibited BC cell proliferation and migration by targeting microRNA (miR)-34a. The expression levels of miR-34a were significantly decreased in BC tissues and cell lines compared with that of adjacent non-tumour tissues and SV-HUC-1 cells. In addition, the expression of miR-34a was inversely correlated with the expression of MALAT1 in BC tissues. The present study revealed that cyclin D1 (CCND1) was identified as a target gene of miR-34a, and its expression was negatively mediated by miR-34a in BC cells. Notably, the upregulation of CCND1 impaired the effect of MALAT1 inhibition on BC cell proliferation and migration. In addition, the expression levels of CCND1 were significantly increased in BC tissues and cell lines. In conclusion, the present findings demonstrated that the knockdown of lncRNA MALAT1 inhibits the proliferation and migration of BC cells by modulating the miR-34a/CCND1 axis, suggesting that the MALAT1/miR-34a/CCND1 axis may be a potential therapeutic target for BC treatment.
机译:已经证明了长期非编码RNA(LNCRNA)转移相关的肺腺癌转录1(Malat1),参与一些常见癌症类型的开发和进展,包括膀胱癌(BC)。然而,MALAT1潜在的BC生长和转移的调节机制仍有待完全阐明。本研究表明,与相邻的非肿瘤组织和正常尿道上皮细胞系SV-HUC-1相比,MALAT1在BC组织和细胞系中显着上调。与第I-II组织中的组织相比,在III-IV BC组织中,MALAT1的表达水平较高。此外,通过靶向microRNA(miR)-34a,MALAT1的敲低显着抑制了BC细胞增殖和迁移。与相邻的非肿瘤组织和SV-HUC-1细胞的相比,BC组织和细胞系中miR-34a的表达水平显着降低。此外,miR-34a的表达与BC组织中MALAT1的表达相反。本研究表明,将细胞周期蛋白D1(CCND1)鉴定为miR-34a的靶基因,其表达被BC细胞中的miR-34a负介导。值得注意的是,CCND1的上调损害了MALAT1抑制对BC细胞增殖和迁移的影响。此外,BC组织和细胞系中CCND1的表达水平显着增加。总之,本研究结果表明,LNCRNA MALAT1的敲低通过调节MIR-34A / CCND1轴来抑制BC细胞的增殖和迁移,表明MALAT1 / MIR-34A / CCND1轴可以是BC的潜在治疗目标治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号